Cigna Group stock was falling sharply after the health insurer missed quarterly earnings estimates and issued light guidance ...

Cigna Group shares fell sharply after the health insurer reported fourth-quarter profit that was dragged down by medical ...

The Cigna Group (NYSE:CI) fell ~9% in the premarket on Thursday after the managed care company's Q4 2024 financials fell short of Street forecasts for earnings due to an unexpected rise in medical ...

Cigna reported fourth-quarter revenue of $65.68 billion, beating analyst estimates of $63.36 billion, according to Benzinga Pro. The company reported fourth-quarter adjusted earnings of $6.64 per ...

Cigna said its medical loss ratio was 87.9% in Q4 2024, compared to 82.2% in the prior-year quarter. For the full-year 2024, MLR was 83.2%, which was still higher compared to the 81.3% its insurance ...

Cigna Group plans to make changes to help lower out-of-pocket cost of prescription drugs, the company said on Wednesday, as ...

President Donald Trump in December said he wanted to “knock out the middleman” in drug purchasing.

Reports Q4 revenue $65.65B, consensus $63.18B. “While higher medical costs in our stop loss product impacted fourth quarter earnings, we are ...

Cigna Group (NYSE: CI) reported its performance in the fourth quarter of 2024, with total revenues reaching $65.6 billion.

In the wake of federal pressure over its prescription costs, Cigna Group is looking to lower the out-of-pocket drug expenses that its patients face by matching the amount to employer contributions and ...

Cigna Healthcare and Providence are expanding their Los Angeles County network, offering customers several additional care ...

TD Cowen analyst Ryan Langston maintained a Buy rating on Cigna (CI – Research Report) today and set a price target of $391.00. The company’s ...